4-[2-(4-Naphthalen-2-yl-phenyl)-ethyl]-benzoic acid | 1228271-97-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 4-[2-(4-Naphthalen-2-yl-phenyl)-ethyl]-benzoic acid
• 英文别名: 4-[2-(4-Naphthalen-2-ylphenyl)ethyl]benzoic acid
• CAS: 1228271-97-3
• 化学式: C₂₅H₂₀O₂
• 分子量: 352.433
• InChiKey: GPUASZZURSTMPM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-[2-(4-Naphthalen-2-yl-phenyl)-ethyl]-benzoic acid methyl ester 在 NaOH 作用下， 以 dioxane-water 为溶剂， 生成 4-[2-(4-Naphthalen-2-yl-phenyl)-ethyl]-benzoic acid
  参考文献：
  名称：

  Lipopeptide Compounds and Their Use

  摘要：

  本发明一般涉及治疗化合物领域，更具体地涉及包括带有脂肪侧链的环肽的某些脂肽化合物（为方便起见，在本文中统称为“LP化合物”），其中，这些化合物具有抗微生物作用，特别是抗菌作用。本发明还涉及包括这些化合物的药物组合物，以及使用这些化合物和组合物，在体外和体内提供抗微生物功能，特别是抗菌功能，以及在治疗由微生物介导的疾病和病症方面的用途，特别是由抗菌功能缓解的细菌疾病，可选地与另一药剂（例如另一抗菌剂）结合使用。

  公开号：

  US20110224129A1

文献信息

• LIPOPEPTIDE COMPOUNDS AND THEIR USE
  申请人：Merlion Pharmaceuticals Pte Ltd.

  公开号：EP2350119A1

  公开（公告）日：2011-08-03
• US8921309B2
  申请人：——

  公开号：US8921309B2

  公开（公告）日：2014-12-30
• [EN] LIPOPEPTIDE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS DE LIPOPEPTIDES ET UTILISATION DE CEUX-CI
  申请人：MERLION PHARMACEUTICALS PTE LT

  公开号：WO2010062264A1

  公开（公告）日：2010-06-03

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain lipopeptide compounds comprising a cyclic peptide bearing a lipid side chain (for convenience, collectively referred to herein as "LP compounds"), which, inter alia, are antimicrobial, particularly antibacterial. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to provide an antimicrobial function, particularly an antibacterial function, and in the treatment of diseases and conditions that are mediated by microbes, particularly bacteria, that are ameliorated by the antimicrobial function, particularly an antibacterial function, including bacterial diseases, optionally in combination with another agent, for example, another antibacterial agent.
• Lipopeptide Compounds and Their Use
  申请人：Boyce Rustum S.

  公开号：US20110224129A1

  公开（公告）日：2011-09-15

  The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain lipopeptide compounds comprising a cyclic peptide bearing a lipid side chain (for convenience, collectively referred to herein as “LP compounds”), which, inter alia, are antimicrobial, particularly antibacterial. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to provide an antimicrobial function, particularly an antibacterial function, and in the treatment of diseases and conditions that are mediated by microbes, particularly bacteria, that are ameliorated by the antimicrobial function, particularly an antibacterial function, including bacterial diseases, optionally in combination with another agent, for example, another antibacterial agent.

  本发明一般涉及治疗化合物领域，更具体地涉及包括带有脂肪侧链的环肽的某些脂肽化合物（为方便起见，在本文中统称为“LP化合物”），其中，这些化合物具有抗微生物作用，特别是抗菌作用。本发明还涉及包括这些化合物的药物组合物，以及使用这些化合物和组合物，在体外和体内提供抗微生物功能，特别是抗菌功能，以及在治疗由微生物介导的疾病和病症方面的用途，特别是由抗菌功能缓解的细菌疾病，可选地与另一药剂（例如另一抗菌剂）结合使用。